Latest news

Invetech, Haemonetics, and Coramed Technologies Receive 2016 Good Design Award® for Development of the TEG® 6s

Her Symptoms Suggested Long Covid. But Was That Too Obvious?

Lysosomal

Biochemical Reagents Market 2023 Unveiling Future Growth, Explores New Trends and Forecasts

US FDA approves Cue Health’s at

Aurinia Files Form S

Apr 01, 2023

Apr 01, 2023

$34.4 million in net revenue for the first quarter of 2023; an increase of 59% over the first quarter of the prior year

Increases 2023 revenue guidance range to $135 - $155 million from net product sales of LUPKYNIS

News Provided by Business Wire via QuoteMedia

Previous: Beckman Coulter Diagnostics announces global launch of immunoassay analyzer Next: Microbiology Testing Market is Set To Fly High in Years to Come

Send inquiry

Send